Hardness characteristics and statistical significance analysis of different ingredients across IDDSI levels^b'*'. by Muxi Chen (9294270)

Subjects:

The catalase enzyme response of <i>A</i>. <i>albopictus</i> larvae decreased (1.5-fold) in response to <i>M</i>. <i>robertsii</i>-derived copper nanoparticles. by Perumal Vivekanandhan (4863484)

Subjects:

Linear covariate analysis of prognostically significant metabolites. Presenting the effect sizes of metabolites that showed significant differences among prognostic groups in ICU-treated COVID-19 patients. Metabolites were included based on an F-value > 2.5 and a p-value < 0.05. Metabolites marked with a single asterisk (*) were significant in both two-way ANOVA and ASCA, whereas those marked with double asterisks (**) were significant only in two-way ANOVA. Positive effect sizes indicate an increase in metabolite concentration between the compared groups, while negative values indicate a decrease. by Emir Matpan (21655811)

“…Positive effect sizes indicate an increase in metabolite concentration between the compared groups, while negative values indicate a decrease.…”

A prepubertal CD decreases fat mass accumulation and prevents lean mass loss in adulthood despite a chronic HFD in Sprague-Dawley male rats. by Ana Aguilar-Lozano (20614619)

Presentation 1_Prehospital tranexamic acid decreases early mortality in trauma patients: a systematic review and meta-analysis.pdf by Yi Li (1144)

“…</p>Conclusion<p>Prehospital TXA decreases early (24-h) mortality in trauma patients without a significant increase in the risk of VTE and other complications, and further studies are still needed to improve and optimize its management strategy.…”

Table 1_Elevated CO2 decreases micronutrient Zn but not Fe in vegetables – evidence from a meta-analysis.docx by Xiaolin Wang (303612)

ROC curves for hub genes. by Jiyong Zhang (2498740)

Subjects:

Differences in immune infiltration between NAFLD and control groups. by Jiyong Zhang (2498740)

Subjects:

Enrichment Analysis Based on Ferroptosis-Related Differentially Expressed Genes. by Jiyong Zhang (2498740)

Subjects:

Correlation between hub genes and 50 hallmark signaling pathways. by Jiyong Zhang (2498740)

Subjects:

ROC curves for hub genes. by Jiyong Zhang (2498740)

Subjects:

Intersection genes obtained from the PPI network and PPI network analysis of intersection genes. colored circles represent genes. by Jiyong Zhang (2498740)

Subjects:

Expression profile heatmaps of key genes in gene sets. by Jiyong Zhang (2498740)

Subjects:

Construction of the WGCNA Co-expression Network. by Jiyong Zhang (2498740)

Subjects:

Differential Gene Expression Associated with Non-Alcoholic Fatty Liver Disease. by Jiyong Zhang (2498740)

Subjects:

Interaction analysis of hub genes. by Jiyong Zhang (2498740)

Subjects:

Presentation 1_Decreased brain-derived neurotrophic factor expression in chronic kidney disease: integrated clinical and experimental evidence.pptx by Juan Chen (61123)

“…</p>Conclusion<p>This study integrated meta-analysis, murine model validation, and single-cell transcriptomic profiling to demonstrate a significant reduction of BDNF in CKD. Furthermore, renal BDNF expression decreased locally, predominantly originating from proximal tubule cells, macrophages, and podocytes, possibly epigenetically inhibited by the upregulation of lnc RNA Bdnf-as.…”

Annual trends in the volumes of open and minimally invasive colostomy reversal, 2012-2022. The proportion of minimally invasive procedures significantly increased over the study pe... by Kevin Tabibian (21601494)

Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”

Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”